Cancer Care


Vaccination of Patients with Newly Diagnosed Glioblastoma Using Autologous Tumor Lysate and Montanide Emulsion for Derivation of Tumor Specific Hybridomas
Principal Investigator (?)
Study Number
This is a non-randomized, open-label study in patients with newly diagnosed glioblastoma to
determine the ability to generate human hybridomas from lymph nodes draining an autologous
tumor vaccine injection and demonstrate that the hybridomas secrete glioblastoma-specific
Phase (?)
Phase II
Sponsor (?)
Available at the following location(s)


View more details from

Contact Information

For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:

Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.